InsidersTradesSigma
Sprint Bioscience AB: directors' dealings · Finland · FIN-FSA
FI:sprint-bioscience-abSE0016609804FI·FIN-FSAMcap 362M€Healthcare
Explore the full management transaction log of Sprint Bioscience AB, a listed issuer based in Finland. Shares are listed on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, Sprint Bioscience AB has recorded 2 reports. Market capitalisation: €361.9m. The latest transaction was reported on 11 December 2025 — Purchase. Among the most active insiders: Björn Sjöstrand. Every trade is free.
2
Insider Decl.
0
Thresholds
€24,019
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2021 · cache
3.43 €
Analyst consensus
1 analysts3.30 €Target 3.30 €(-4%)3.30 €
Income statement
Revenue167.2 M€
Gross profit154.1 M€92% margin
Net income91.7 M€54.8% margin
Valuation
PER (trailing)3.5x
P/Book3.0x
Beta-0.52
Balance sheet & cash
Market cap361.9 M€
Free Cash Flow83.4 M€
Profitability & ownership
ROE142.8%
ROA68.2%
% insiders35.2%
% institutions31.7%
Last declaration on 11 December 2025
Declarations2 total
Executives●Purchase13FIN-FSA
€3,99730,000 shares@ €0.13320.0011% mcap16.6% of flow
Aktie
FI:A003U606-1·
Ideal exit: 6 Sept 2026 (T+270)
Executives●Purchase19FIN-FSA
€20,022333,520 shares@ €0.060.0055% mcap83.4% of flow
BTA (betald tecknad aktie)
FI:A003N847-2·
Ideal exit: 24 Jan 2026 (T+270)
2 of 2 declarations